Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.5K

Epidemiological and laboratory features of chronic hepatitis B cases in the interval 2010-2013

A S Luca, Carmen Dorobăţ, Ramona Gabriela Ursu

    Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
    |August 1, 2014
    PubMed

    Insights

    Chronic hepatitis B virus infection impacts public health. This study links higher viral load to increased liver fibrosis, especially in HBeAg-negative patients.

    Area of Science:

    • Hepatology
    • Virology
    • Epidemiology

    Background:

    • Hepatitis B virus (HBV) infection poses a significant global health challenge due to its transmissibility and potential to cause severe liver disease, including cirrhosis and hepatocellular carcinoma.
    • Understanding the epidemiological and laboratory characteristics of chronic HBV infection is crucial for effective management and treatment strategies.

    Purpose of the Study:

    • To analyze the epidemiological and laboratory features of chronic hepatitis B virus infection.
    • To investigate the correlation between HBV viral load, HBeAg status, and liver fibrosis progression.

    Main Methods:

    • Retrospective analysis of patients with chronic hepatitis B admitted to a university hospital between January 1, 2010, and December 31, 2020.
    • Evaluation of patient demographics, alanine aminotransferase (ALAT) levels, hepatitis B e antigen (HBeAg) status, HBV viral load, and liver fibrosis staging (F2-F4).

    Main Results:

    • The study population comprised middle-aged males, predominantly from urban areas.
    • Elevated ALAT levels were common and associated with increased fibrosis prevalence, irrespective of HBeAg status.
    • A significant correlation was observed between higher HBV viral load and increased prevalence of liver fibrosis (F2-F4), particularly in HBeAg-negative patients.

    Conclusions:

    • The findings highlight a significant association between HBV viral load and the degree of liver fibrosis.
    • Viral load and HBeAg status are important factors influencing fibrosis progression in chronic hepatitis B patients.
    • These results underscore the importance of monitoring viral load in managing chronic HBV infection to mitigate liver damage.
    Abstract

    More Related Videos

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

    Published on: November 7, 2018

    21.5K
    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

    Published on: February 19, 2019

    13.1K

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
    78
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
    21
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    271
    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    25
    Infectious Diseases and Their Occurrence01:28

    Infectious Diseases and Their Occurrence

    Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
    83